O narzędziu
PathAI is an AI-powered pathology platform that assists pathologists in diagnosing cancer, inflammatory diseases, and rare conditions from whole-slide histology images. Its AISight platform is deployed in clinical and research settings to improve diagnostic accuracy and throughput. PathAI has published over 75 peer-reviewed studies and partnered with Bristol Myers Squibb and AstraZeneca for drug development applications. FDA-cleared algorithms are available for H&E-stained tissue analysis.
Model cenowy
Enterprise / Pharma
Kontakt
Lab licensing and pharma partnerships; contact PathAI
Stan cen: March 2026
Głosy Top234
Głosy Hot220